# NEOPROBE CORP: Form D filing

NEOPROBE CORP, a biotechnology company in Dublin, OH, filed a Form D with the SEC in 2010. The latest, on July 7, 2010, reports $14 million sold of a $14 million offering to 3 investors.

Find out what NEOPROBE CORP does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20NEOPROBE%20CORP%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=NEOPROBE%20CORP&page=%2Fdata%2Fform-d%2Fcompany%2Fneoprobe-corp-810509)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20NEOPROBE%20CORP%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=NEOPROBE%20CORP&page=%2Fdata%2Fform-d%2Fcompany%2Fneoprobe-corp-810509)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Ohio](https://specstream.ai/data/form-d/state/ohio): 1,071 rows, by operating companies, filed since November 1, 2024, $53.55, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/ohio
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 425 METRO PLACE NORTH, SUITE 300, Dublin, OH, 43017
- Phone: (614) 793-7500
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: $5,000,001 - $25,000,000
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 810509

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jul 7, 2010 | New notice | $14,000,000 | $14,000,000 | $0 | 3 | Jun 22, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/810509/000094926510000005/0000949265-10-000005-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Reuven C. Avital | Director |  |
| Gordon A. Troup | Director |  |
| Douglas L. Rash | Executive Officer |  |
| Fred B. Miller | Director |  |
| J. Frank Whitley, Jr. | Director |  |
| Anthony K. Blair | Executive Officer |  |
| Brent L. Larson | Executive Officer |  |
| Rodger A. Brown | Executive Officer |  |
| Carl J. Aschinger, Jr. | Director |  |
| Owen E. Johnson | Director |  |
| Frederick O. Cope | Executive Officer |  |
| Kirby I. Bland | Director |  |
| David C. Bupp | Executive Officer, Director |  |

## Other biotechnology companies in Ohio that filed recently

- [LAACClamp Inc.](https://specstream.ai/data/form-d/company/laacclamp-inc-2104335) $900,000 · Oct 5, 2026
- [Autology, Inc.](https://specstream.ai/data/form-d/company/autology-inc-2154840) $3.4 million · Sep 30, 2026

[Every Form D from the week of Jul 5, 2010](https://specstream.ai/data/form-d/week/2010-07-05) · [All recent filings in Ohio](https://specstream.ai/data/form-d/state/ohio) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what NEOPROBE CORP reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).